UK markets open in 44 minutes
NIKKEI 225
38,219.71 -54.34 (-0.14%) HANG SENG
18,187.84 +424.81 (+2.39%) CRUDE OIL
79.51 +0.51 (+0.65%) GOLD FUTURES
2,323.50 +12.50 (+0.54%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
45,877.43 -1,850.56 (-3.88%)
BriaCell Therapeutics Corp. (BCTX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 33.52M |
| Enterprise value | 27.28M |
| Trailing P/E | 719.00 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 17.03 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -0.95 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.75 |
| 52-week change 3 | -69.86% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 7.5900 |
| 52-week low 3 | 2.0100 |
| 50-day moving average 3 | 2.7594 |
| 200-day moving average 3 | 4.6403 |
Share statistics
| Avg vol (3-month) 3 | 81.73k |
| Avg vol (10-day) 3 | 26.74k |
| Shares outstanding 5 | 15.98M |
| Implied shares outstanding 6 | 16.02M |
| Float 8 | 11.64M |
| % held by insiders 1 | 12.27% |
| % held by institutions 1 | 13.87% |
| Shares short (15 Apr 2024) 4 | 685.02k |
| Short ratio (15 Apr 2024) 4 | 7.14 |
| Short % of float (15 Apr 2024) 4 | 4.89% |
| Short % of shares outstanding (15 Apr 2024) 4 | 4.29% |
| Shares short (prior month 15 Mar 2024) 4 | 733.32k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 02 Jan 2020 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:300 |
| Last split date 3 | 02 Jan 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Jul 2023 |
| Most-recent quarter (mrq) | 31 Jan 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -85.45% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -31.7M |
| Net income avi to common (ttm) | -12.61M |
| Diluted EPS (ttm) | -0.7900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 6.24M |
| Total cash per share (mrq) | 0.39 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 2.99 |
| Book value per share (mrq) | -0.50 |
Cash flow statement
| Operating cash flow (ttm) | -31.26M |
| Levered free cash flow (ttm) | -19.76M |
© 2024 Yahoo. All rights reserved.